Pediatric Pharmacokinetics Human Development and Drug Disposition

被引:35
|
作者
Funk, Ryan S. [1 ]
Brown, Jacob T. [1 ]
Abdel-Rahman, Susan M. [1 ,2 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Pediat, Sch Med, Kansas City, MO 64108 USA
关键词
Pediatric; Pharmacokinetic; Development; Absorption; Distribution; Metabolism; Excretion; Transport; SINGLE-DOSE PHARMACOKINETICS; PLASMA-PROTEIN BINDING; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION; HUMAN LIVER; POPULATION PHARMACOKINETICS; INTRAVENOUS OMEPRAZOLE; HEALTHY-VOLUNTEERS; PRETERM INFANTS; SMALL-INTESTINE;
D O I
10.1016/j.pcl.2012.07.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
引用
收藏
页码:1001 / +
页数:17
相关论文
共 50 条
  • [41] Pediatric Drug Development
    Walson, Philip D.
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 154 - 155
  • [42] Pediatric Drug Development
    Kratochvilova, Hana
    CHEMICKE LISTY, 2014, 108 (09): : 904 - 904
  • [43] IMPACT OF THE HUMAN GUT MICROBIOME ON DRUG DISPOSITION
    Turnbaugh, Peter
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S9 - S9
  • [44] Disposition and Development of Human Fat Tissue
    Berg, W.
    ZEITSCHRIFT FUR MORPHOLOGIE UND ANTHROPOLOGIE, 1910, 13 : 305 - 342
  • [45] A Model-Based Approach to Predicting the Human Pharmacokinetics of a Monoclonal Antibody Exhibiting Target-Mediated Drug Disposition
    Luu, Kenneth T.
    Bergqvist, Simon
    Chen, Enhong
    Hu-Lowe, Dana
    Kraynov, Eugenia
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 341 (03): : 702 - 708
  • [46] PHARMACOKINETICS OF PIRAZOLAC - A NEW ANTI-INFLAMMATORY DRUG IN HUMAN VOLUNTEERS .1. ABSORPTION, DISPOSITION, BIOTRANSFORMATION AND EXCRETION
    TAUBER, U
    WEISS, C
    KRAUSE, W
    ACKSTEINER, B
    MATTHES, H
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1985, 10 (01) : 41 - 53
  • [47] Impact of drug-drug interactions on phenobarbital pharmacokinetics in pediatric patients
    Sima, Martin
    Slanar, Ondrej
    EPILEPSIA, 2019, 60 (06) : 1266 - 1267
  • [48] Pharmacokinetics and Disposition of Nanomedicine Using Biodegradable PEG/PCL Polymers as Drug Carriers
    Wang, YuJun
    Gou, MaLing
    Gong, ChangYang
    Wang, Cheng
    Qian, ZhiYong
    Lin, Yun Feng
    Luo, Feng
    CURRENT DRUG METABOLISM, 2012, 13 (04) : 338 - 353
  • [49] DISPOSITION, PHARMACOKINETICS, AND METABOLISM OF A POTENTIAL ANTILEISHMANIAL DRUG IN SYRIAN GOLDEN-HAMSTERS
    THEOHARIDES, A
    ANDERS, J
    RIDDER, W
    SMYTH, M
    CHUNG, H
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 959 - 959
  • [50] Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics
    Iwatsubo, T
    Hirota, N
    Ooie, T
    Suzuki, H
    Sugiyama, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1996, 17 (04) : 273 - 310